Screener
Kyverna Therapeutics, Inc. KYTX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Kyverna Therapeutics, Inc.’s reported figures.
The source filing: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219397
FAQ
- What is Kyverna Therapeutics, Inc.'s enterprise value?
- Kyverna Therapeutics, Inc. (KYTX) reported enterprise value of $498.7M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s enterprise value changed year-over-year?
- Kyverna Therapeutics, Inc.'s enterprise value increased by 1393.4% year-over-year, from $33.39M to $498.7M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Kyverna Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude